WorldQuant Millennium Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.7M Buy
101,177
+82,666
+447% +$20.6M 0.09% 212
2025
Q4
$4.46M Buy
18,511
+9,074
+96% +$2.32M 0.02% 343
2025
Q3
$2.58M Buy
9,437
+4,780
+103% +$1.31M 0.01% 359
2025
Q2
$1.2M Buy
+4,657
New +$1.11M 0.01% 388
2024
Q4
Sell
-105,675
Closed -$25.8M 499
2024
Q3
$25.8M Sell
105,675
-156,941
-60% -$35.1M 0.19% 141
2024
Q2
$50.3M Buy
262,616
+137,834
+110% +$28M 0.46% 63
2024
Q1
$24.7M Buy
124,782
+82,942
+198% +$15.2M 0.3% 101
2023
Q4
$7.2M Sell
41,840
-208,517
-83% -$32M 0.1% 204
2023
Q3
$37M Buy
250,357
+81,537
+48% +$14.7M 0.57% 51
2023
Q2
$36.9M Buy
+168,820
New +$37.6M 0.62% 38

Other funds holding RMD

WorldQuant Millennium Advisors's RMD Position: Q1 2026 in Review

WorldQuant Millennium Advisors increased its ResMed (RMD) stake by 447% in Q1 2026, buying an estimated $20.6M and bringing the position to 101,177 shares worth $22.7M. The position accounts for 0.09% of the portfolio, ranked #212.

WorldQuant Millennium Advisors first reported a position in RMD in Q2 2023 and has held it in 10 quarters since. The position peaked at $50.3M in Q2 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • WorldQuant Millennium Advisors held 101,177 shares of ResMed worth $22.7M as of Q1 2026.
  • WorldQuant Millennium Advisors bought 82,666 ResMed shares in Q1 2026, an estimated $20.6M.
  • ResMed made up 0.09% of WorldQuant Millennium Advisors's portfolio in Q1 2026, its #212 holding.
  • WorldQuant Millennium Advisors first reported a position in ResMed in Q2 2023 and has held it in 10 quarters since.
  • WorldQuant Millennium Advisors's ResMed position peaked at $50.3M in Q2 2024.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q1 2026, filed 15 May 2026.